Upload
independent
View
1
Download
0
Embed Size (px)
Citation preview
Full Paper
852
Photopolymerized Injectable RGD-ModifiedFumarated Poly(ethylene glycol) DiglycidylEther Hydrogels for Cell Growth
Z. Seden Akdemir, Handan Akcakaya, M. Vezir Kahraman, Taskın Ceyhan,Nilhan Kayaman-Apohan, Atilla Gungor*
In this study, photopolymerized hydrogels of fumarated poly(ethylene glycol) diglycidyl-co-poly(ethylene glycol) diacrylate have been synthesized and modified with cell adhesionpeptide, Arg-Gly-Asp (RGD). The structural and mechanical properties of the hydrogels arefound to be poly(ethylene glycol) diacrylate (PEGDA) dependent. The percentage of gelation isincreased from 72 to 89 wt.-% when the amount of the crosslinker co-monomer (PEGDA) in thehydrogel formulation is increased from 20 to 40 wt.-%. In the present case, the equilibriummass swelling is decreased from 216 to 93%. The viscosities of the uncured formulations havealso been measured and likewise, the resultswere influenced by the increasing amount ofPEGDA that reduced the value from 83 to36 cP. The compressive modulus of the preparedhydrogels was improved with the addition of thePEGDA. Cell growth experiments have been per-formed by comparing the properties of the hydro-gels with and without RGD units. The resultsshow that RGD units enhance the adhesion ofcells to the surface of the hydrogels. SEM-EDSstudies reveal that nitrogen and calcium areproduced on the osteoblast-seeded surface ofthe scaffold within the culture time period.
Introduction
Tissue engineering is an interdisciplinary field that applies
the principles of engineering and biomedical sciences
Z. S. Akdemir, M. V. Kahraman, N. Kayaman-Apohan, A. GungorDepartment of Chemistry, Marmara University, 34722 Goztepe-Istanbul, TurkeyFax: þ90 216 3478783; E-mail: [email protected]. AkcakayaBiophysics Department, Istanbul University Capa-Istanbul, TurkeyT. CeyhanCevre Hospital Mecidiyekoy-Istanbul, Turkey
Macromol. Biosci. 2008, 8, 852–862
� 2008 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
toward the development of biological substitutes that
restore, maintain, or improve tissue or organ function.[1,2]
A tissue engineered implant is a biologic–biomaterial
combination in which cells are transplanted to penetrate
and proliferate in all directions to populate all regions of
the implant. Cell proliferation can be facilitated and enhanced
with the introduction of a cell adhesive sequence. The
properties of the implant such as biocompatibility,
porosity, biodegradability, and interconnectivity have an
impressive role in the formation of the new tissue.[3]
Recent developments have shown that hydrogels are
good candidates for tissue-engineered implants because of
their hydrophilic structure, which gives them physical
DOI: 10.1002/mabi.200700319
Photopolymerized Injectable RGD-Modified Fumarated Poly(ethylene glycol) . . .
characteristics similar to tissue.[4,5] A cell-transplanted
hydrogel acts as a temporary support system for the
growing new cells, which can reorganize into functional
tissue as the hydrogel degrades. Many synthetic hydrogels
have been investigated for tissue engineering applications
including poly(vinyl alcohol) (PVA),[6,7] poly(L-lactic acid)
(PLA), poly(glycolic acid) (PGA) and their copolymers,[8–10]
and poly(ethylene glycol) (PEG) and poly(ethylene glycol)-
based copolymers.[11–15]
PEG, also known as poly(ethylene oxide), has a very
hydrophilic nature that restricts the adhesion of proteins
and cells, but by using PEG in a co-polymer, it enhances the
biocompatibility of the composition and also enables
researchers to determine the cell attachment character-
istics of the prepared hydrogel.[2,16] Nevertheless, the
PEGylation method allows a protein, peptide, or non-
peptide molecule to be linked to PEG chains, to supply a
better hydrogel–cell interconnectivity.[17]
Injectable biomaterials are preferred in bone treatment
since they present a potential to minimize the invasive-
ness of some surgical techniques. Moreover, they can
easily be combined with the desired cells or growth
factors in a solution state prior to injection and have the
ability to fill the damaged area completely.[18–20] Photo-
polymerized hydrogel systems demand the above require-
ments. They elicit better temporal and spatial control over
the gelation process, minimal heat production, ability to
uniformly encapsulate cells, are operational at low
temperature, minimize the damage to the entrapped
bioactive agents or cells during hydrogel formation, and
are injectable in nature before in-situ polymeriza-
tion.[21–24] Practically, the low viscosity liquid hydrogel
formulation can be easily placed into complex shaped
areas through a small crease by injection and subse-
quently in-situ polymerization can be achieved by using a
fiber optic cable connected to a UV processor.[25] From this
aspect, hydrogels can be used to fill irregularly damaged
sections, to allow minimally invasive surgical procedures,
and to act as a facilitator to incorporate with cells.[2]
Poly(ethylene glycol) diacrylate (PEGDA) is a promising
tissue engineering material, because its fairly low-
viscosity prepolymer solution can be applied to tissue
and can be photopolymerized in situ to form a hydrogel
film on the tissue surface.
One of the prime goals of this study was to synthesize a
new PEG-based resin that has two repeating units,
poly(ethylene glycol) diglycidyl ether (PEGDGE) and
fumaric acid (FA), which are linked to each other by ester
bonds. Insertion of double bonds into a PEG chain enables
the formation of a crosslinked network by photopolymer-
ization in the presence of a radical initiator. Photopoly-
merizable hydrogel formulations that contain the new
synthesized resin are reinforced with PEGDA. Moreover,
PEGDA would adjust the viscosity of the formulations and
Macromol. Biosci. 2008, 8, 852–862
� 2008 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
provides extra double bonds to the compositions, thereby
increasing the crosslink density.
Another task was to support the cell adhesion in the
prepared hydrogel matrix. Hence, we used Arg-Gly-Asp
(RGD) as a cell-adhesive peptide. RGD is a minimal peptide
sequence, found throughout the body including many
bone extracellular matrix proteins. It is stable because of
its short peptide sequence and can be coupled to the amine
of reactive-N-terminated PEG chains.[26,27] Poly(ethylene
glycol) monoacrylate can be modified with 1,10-carbonyl-
diimidazole (CDI) to yield amine-reactive acylimidazole-
terminated PEG chains, which can subsequently be
covalently bonded to RGD.
This paper represents the synthesis and the character-
ization studies of the poly(ethylene glycol) diglycidyl
fumarate (fumarated PEGDGE) and RGD-attached poly
(ethylene glycol) monoacrylate (RGD-PEGMA) resins. The
formulations composed of fumarated PEGDGE, PEGDA,
and RGD-PEGMA in water were crosslinked by photopoly-
merization techniques in the presence of a photoinitiator
to form a novel hydrogel. Before the photopolymerization
step, the viscosity of each formulation was determined.
Mechanical properties of the hydrogels were analyzed by
compressive testing. Furthermore, it was investigated
whether the hydrogels could serve as a tissue-engineering
scaffold.
Experimental Part
Materials
PEGDGE (Mn ¼ 526), poly(ethylene glycol) monoacrylate (PEGMA,
Mn ¼375), PEGDA (Mn ¼ 258), and FA, were purchased from
Aldrich Chemical Co. RGD was obtained from Sigma. CDI and
triphenyl phosphine (TPP) were provided by Fluka AG. The
photoinitiator 1-hydroxy cyclohexyl phenyl ketone (Irgacure-184)
was purchased fromCiba Speciality Chemicals. All other chemicals
were of analytical grade and were purchased from Merck AG.
Freshly double-distilled water was used throughout.
Synthesis of Fumarated PEGDGE
FA (6.2 g, 0.0532 mol, equivalent to 40% of the total epoxy content
in PEGDGE), was added to a three-neck round-bottomed flask
charged with 70 g (0.266 mol) of PEGDGE and 0.7 g of TPP (as a
catalyst, 1% w/w). The reaction was stirred mechanically under
nitrogen atmosphere at 80 8C until the acid value (mg KOH � g�1) of
the resinwas less than one. The acid value of the fumarated PEGDE
resin showed that all the acid groups had reacted with epoxy
groups. At the end of the reaction the resulting resin (PEGMA)was
analyzed by FT-IR spectroscopy. The epoxy content was deter-
mined by a titration method (ASTM D1652). Fumaric acid-
modified PEGDGE was prepared as shown in Scheme 1.
IR (NaCl): 3 400 (–OH), 1 720 (C––O), 1 650 (C––C), 1 250 cm�1
(C–O–C).
www.mbs-journal.de 853
Z. S. Akdemir, H. Akcakaya, M. V. Kahraman, T. Ceyhan, N. Kayaman-Apohan, A. Gungor
Scheme 1. Modification of PEGDGE with FA.
854
Activation of PEGMA with CDI
PEGMA (26.6 mmol) was transferred into a three-neck round-
bottomed flask filled with tetrahydrofuran (THF) and purged with
nitrogen. A solution was obtained by stirring magnetically. CDI
(29.3 mmol) was added to the reaction flask and the temperature
was raised to 40 8C and the mixture was stirred
overnight. THF was then distilled off by rotary
evaporation and the by-productswere removed by
dialysis against water. The hydroxy group of the
PEGMA was reacted with CDI to yield the
amine-reactive-N-acylimidazole.
IR (NaCl): 3 400 (imide), 1 755 (C––O str. for
imidazole), 1 720 cm�1 (C––O str. for acrylate).
Attachment of RGD into
N-Acylimidazole Tethered PEGMA
RGD (10mg) was dissolved in 10mL of 50� 10�3M
NaHCO3 solution (pH 8.2). N-Carbonylimidazole-
tethered PEGMA (0.8 g) was added dropwise to the
peptide solution and the mixture was gently
shaken at room temperature for 24 h. RGD-attached
PEGMA was frozen at �80 8C and lyophilized.
N-Acylimidazole-tethered PEGMA was coupled to
RGD as shown in Scheme 2.1H NMR (D2O/CD3OD, 1: 2): d¼2.4 (CH2–CH2–
CH2–NH–C(––NH)–NH2, arginine), 2.8 (–CH2–COOH,
aspartic acid), 3.0 (CH2–CH2–CH2–NH–C(––NH)–
NH2, arginine), 4.1–4.2 (–O–CH2–CH2–OH), 6.8–7.2
(acrylate).
Scheme 2. Attachment of RGD into N-acylimidazole tethered PEGMA.
Characterization of the Resins
The structure of fumarated PEGDGE and
N-acylimidazole-tethered PEGMA were analyzed
by FT-IR spectroscopy. RGD-PEGMA was charac-
terized using 1H NMR spectroscopy. 1H NMR
spectra were obtained using a Varian model
T-60 NMR spectrometer operated at 200 MHz.
FT-IR spectra were obtained on a Shimadzu 8300
FT-IR spectrophotometer.
Macromol. Biosci. 2008, 8, 852–862
� 2008 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
Synthesis and Characterization of Hydrogels
Hydrogel formulations were prepared by mixing component A,
which consisted of an aqueous solution of the RGD-PEGMA
(10% w/v) with component B, which consisted of a mixture of
fumarated PEGDGE and PEGDA, at a total weight concentration of
18/82%. Component B was varied by changing the amount of the
PEGDA in the total mixture. Table 1 represents the composition of
the formulations. All of the formulations, which contain
Irgacure-184 (photoinitiator), were placed into a Teflon mold in
which the wells dimensions were 10 mm in diameter and 2 mm
in depth, to perform the UV-initiated crosslinking reaction. The
samples were irradiated for 10 min under a high-pressure UV
lamp (OSRAM 300 W, lmax¼ 365 nm) and the obtained hydrogels
were then removed from the wells.
Hydrogel samples were immersed in a large excess of distilled
water for a day to remove any unreacted monomers and residual
initiator. All of the hydrogels were dried in a vacuum oven at 30 8Cfor several days until reaching a constant weight. The dry gels
were weighed (Wi) and soaked in distilled water at room
temperature (20.0� 0.1 8C). The swollen gels were removed from
DOI: 10.1002/mabi.200700319
Photopolymerized Injectable RGD-Modified Fumarated Poly(ethylene glycol) . . .
Table 1. The composition of the hydrogel formulations.
Hydrogel Component A Component B Photoinitiator
Water RGD-modified PEGMA FA-modified PEGDGE PEGDA g
g g g g
FPEG20 2.0 – 8.0 2.0 0.2
FPEG20-2 2.0 0.2 8.0 2.0 0.2
FPEG30-2 2.0 0.2 7.0 3.0 0.2
FPEG40-2 2.0 0.2 6.0 4.0 0.2
FPEG20-6 2.0 0.6 8.0 2.0 0.2
the distilled water, gently wiped with filter paper to remove any
water at the surface and weighed (Ws). Finally, all of the swollen
gels were kept at�80 8C overnight and then lyophilized. The dried
hydrogels were weighed (Wd).
The degree of gelation was calculated by using the formula:
Macrom
� 2008
Gelation ð%Þ ¼ ðWd=WiÞ � 100 (1)
The degree of swelling was calculated by using the formula:
Swelling ð%Þ ¼ ½ðWs �WdÞ=Wd� � 100 (2)
Degradation of Hydrogels
Degradation behavior of the hydrogels was investigated by the
following method. The vacuum dried hydrogels were weighed
(W0) and transferred into phosphate-buffered saline (PBS) (pH 7.4)
at 37 8C. Each pre-weighed hydrogel was kept in the buffer
solution until a specified time was reached and then removed.
Samples were dried under vacuum and thenmeasured to obtain a
final weight (Wdt). The weight loss of the hydrogels was calculated
by using Equation (3).
Total weight loss ð%Þ ¼ ðW0 �Wdt=W0Þ � 100 (3)
Rheometry
The viscosity of the prepared formulations was measured before
the photocrosslinking process using a Brookfield RV DV-IIþ Pro
Viscometer. The formulation was placed into a Teflon mold
(20mm in diameter and 70 mm in depth) and positioned on the
temperature-controlled plate. The temperature was set to 37 8C.The viscosity was measured with a spindle speed of 200 rpm.
Compressive Mechanical Testing
Compressive testing of hydrogels was conducted using a
mechanical testing system Zwick Roell BDO-FBO.5TH. For
compression measurement, hydrogels were prepared in a
ol. Biosci. 2008, 8, 852–862
WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
cylindrical shape by using a glass tube with a depth of 70mm and
14 mm in diameter. Each of the formulation solutions was poured
into these tubes and photopolymerized under a UV lamp for
10min. After polymerization, all of the cylindrical shaped samples
were removed from the glass tube and cut into 10 mm pieces.
Hydrogel cylinders were compressed in a wet state at a crosshead
speed of 5 mm �min�1 while stress and strain were monitored
throughout. The fracture strength and compressive strain was
evaluated by using software called Test Xper in Zwick Roell
BDO-FBO.5TH. The compressive modulus was calculated from the
linear region of the stress–strain curve of the compression test.
Differential Photocalorimetry
Photopolymerization of the hydrogel formulation was carried out
by Pyris Diamond DSC equipped with an EXFO Omni-Cure 2000
photo-DSC accessory. Filtered light (250–450 nm) with an
intensity of 20 mW � cm�2 at the tip of the light guide was used.
Approximately 150 mg of each sample was placed in the
aluminum differential scanning calorimetry (DSC) pans.
Heat flow vs. time curves were recorded in an isothermal mode
under a nitrogen flowof 20mL �min�1 at 37 8C. The rate of reactionin these experimentswas calculated by the following equation:[28]
Rp ¼ ðH=WÞ=DH (4)
where Rp is the rate of polymerization in s�1, H is the heat flow in
mW, W is the weight of monomer solution in mg and DH is the
enthalpy of the material in J � g�1.
The heat liberated during the polymerization reaction was
directly proportional to the number of vinyl groups reacted in the
system. By integrating the area under the exothermic peak, the
conversion of the vinyl groups (C) could be calculated by:[29]
C ¼ DHt=DHtheor0 (5)
where DHt is the heat evolved at time t, and DHtheor0 is the
theoretical heat for complete conversion.[30]
In vitro Studies of the Cell-Seeded Hydrogels
3T3 mouse fibroblasts were grown in Dulbecco’s Modified Eagle
Medium (DMEM)/F12 medium containing 10% fetal calf serum,
www.mbs-journal.de 855
Z. S. Akdemir, H. Akcakaya, M. V. Kahraman, T. Ceyhan, N. Kayaman-Apohan, A. Gungor
Figure 1. FT-IR spectra of a) Fumarated PEGDGE and b)N-carbonylimidazole tethered PEGMA
856
100 IU �mL�1 penicillin, and 0.1 mg �mL�1 streptomycin and were
kept in a controlled-atmosphere (5% CO2) incubator at 37 8C.Osteoblasts were obtained from the fourth and fifth passages of a
differentiation process of human bone marrow mesenchymal
stromal cells (MSCs). At subconfluence, MSCs were detached with
trypsin-EDTA and were grown in DMEM-low glucose (DMEM-LG)
with the addition of the osteogenic differentiation medium.[31]
For cell seeding, hydrogels with and without RGD peptide units
were prepared as described above. The hydrogels were sterilized
using 100% ethanol and then placed in 6-well tissue culture plates.
Cells were seeded on the surface of the hydrogels at an
approximate density of 105 cells �mL�1. After 24 h, the hydrogels
were taken out from the medium, rinsed twice with sterilized PBS
solution and the cells were then fixed with 2.5% glutaraldehyde
for 20 min. After fixation, the hydrogels were washed with PBS
solution once again. The lyophilization was performed at �100 8Cfor 20 min. Invert microscopy (Olympus UK) was used to
investigate cell–hydrogel interactions. The morphological topol-
ogy of the fibroblast-seeded surface images were taken on a
Philips XL30 ESEM FEG environmental scanning electron micro-
scope which made it possible to examine the materials in their
natural, uncoated state under low vacuum around 0.6–0.8 Torr
and at 10 kV. The samplemorphologies were investigated at room
temperature to reveal their natural surface characteristics by
using a special technique (gaseous low vacuum mode) that
allowed charge-free, gaseous secondary electrons. In addition,
scanning electron microscopy (SEM) was performed using a SEM
JOEL JSM-5910 LV. The specimens were prepared for SEM by
lyophilization at �80 8C and the dehydrated samples were placed
in liquid nitrogen until the SEM examination, which was
performed on the same day. An approximately 300 A gold coating
was applied using an Edwards S 150 B sputter coater.
Results and Discussion
Synthesis of Fumarated PEGDGE
PEGDGEwasmodified with fumaric acid in the presence of
triphenylphosphine, which is used as a catalyst. When the
amount of the epoxy groups reacted was calculated to be
40% of the total epoxy content, the reaction was
terminated. An FT-IR spectrum of the fumarated resin is
shown in Figure 1a. As seen in Figure 1a, a broad band
appears at 3 400 cm�1, which indicates the secondary
hydroxy (–OH) groups of the newproduct. A strong band at
1 720 cm�1 also illustrates ester bond formation because of
the reaction between fumaric acid and epoxy groups. The
band at 1 650 cm�1 belongs to the double bonds of the
fumaric acid, which is incorporated into the polymeric
chain during the reaction. One can also clearly see the
etheric C–O–C bond stretch at 1 250 cm�1.
Activation of PEGMA with CDI and Attachmentof RGD
CDI is often used for the coupling of amino acids or
peptides. It may easily react with the hydroxy group of the
Macromol. Biosci. 2008, 8, 852–862
� 2008 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
PEGMA to produce a derivative that is sensitive to
nucleophiles. Therefore, at the end of the activation
reaction, it is sensible to expect the replacement of the
O–H stretching band with an imide band in the FT-IR
spectrum of theN-acylimide-terminated PEGMA. Figure 1b
is the spectrum of the N-acylimide-terminated PEGMA. At
3 400 cm�1 a newly formed imide band has appeared
while the –OH streching band has disappeared. Two
different carbonyl groups, one from the acrylate and the
other from the imidazole groups cause a split in the band
at 1 750 cm�1.
After RGD was attached to N-acylimide-terminated
PEGMA, 1H NMR analysis of the new product was
performed in a mixture of D2O and CD3OD (1: 2). As seen
in Figure 2, the 1H NMR spectrum of RGD-attached PEGMA
shows broad multiples that range from 2.4 to 3.0 ppm.
These multiples are attributed to the CH2–CH2–CH2–NH–
C(––NH)–NH2 group of arginine, which appears around
2.4 ppm, a multiplet of the –CH2–COOH of aspartic acid at
2.8 ppm, and a triplet of CH2–CH2–CH2–NH–C(––NH)–NH2
of arginine at 3.0 ppm. Ethylene glycol groups, –O–CH2–
DOI: 10.1002/mabi.200700319
Photopolymerized Injectable RGD-Modified Fumarated Poly(ethylene glycol) . . .
Figure 2. Proton NMR spectra of RGD-attached PEGMA.
CH2–OH, show triplet peaks at 4.1 and 4.2 ppm. The proton
peaks of the acrylate group are at 6.8 and 7.2 ppm.
Gel Percentage and Equilibrium Mass Swelling of theHydrogels
Table 2 shows the gelation percentages and the equili-
brium mass swelling results of the hydrogels. It can be
seen in Table 2 that the hydrogel with 20 wt.-% of PEGDA
content has a 52 wt.-% gel fraction. It is thought that
various factors such as the formulation viscosity, the film
thickness, and initiator content may influence the gel
content. Because of the mobility restrictions that appear
upon gelation and ultimately vitrification of the
Table 2. Characterization of the hydrogels.
Sample
No.
Gel
percentage
Equilibrium %
mass swelling
Vis
wt.-%
FPEG20-2 52W 2.4 216W 4.1
FPEG30-2 62W 2.1 151W 4.0
FPEG40-2 69W 1.9 93W 3.7
Macromol. Biosci. 2008, 8, 852–862
� 2008 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
UV-exposed sample, a decrease in conversion takes place.
In addition, because of the well-known screening effect,
UV light cannot penetrate sufficiently deeply into the
sample and high conversion could not be achieved. As seen
in Table 2, the gelation percentages increase from 52 to 69
wt.-% with an increase in PEGDA content in the hydrogel
formulation. This is because the double bonds of PEGDA
provide an additional contribution to the crosslinking
process. It is known that the degree of crosslinking and the
swelling behavior of the hydrogel are diversely related to
each other. Therefore, the decrease in swelling is expected
upon increasing the PEGDA content of the hydrogel
formulation. In the present case, the equilibrium mass
swelling is decreased from 216 to 93%.
cosity Fracture
strength
Compressive
modulus
Heat
release
cP N �mmS2 N �mmS2 J � gS1
85 0.11W 0.02 0.74W 0.05 20.74
49 0.35W 0.07 1.56W 0.16 22.86
36 1.09W 0.12 3.60W 0.23 25.93
www.mbs-journal.de 857
Z. S. Akdemir, H. Akcakaya, M. V. Kahraman, T. Ceyhan, N. Kayaman-Apohan, A. Gungor
858
Degradation
Degradable biomaterials are essential in orthopaedic
applications because second surgical intervention is not
necessary to remove the implant after a certain time.[8] In
several studies, it has been reported that the degradation
of the hydrogels could be measured by weighing the
swollen hydrogels in PBS at a certain time.[5,7,8] Anseth
et al.[7] synthesized a degradable and photocrosslinkable
hydrogel scaffold based on PVA and emphasized that
during degradation, hydrogels slowly hydrolyzed and the
structure of the network dramatically changed. This
behavior was reported because the network became
swollen and imbibed more water as the crosslinks in
the network were cleaved. However, in this study a
significant increase in water absorption of the hydrogel
samples was not observed during the first 20 weeks in PBS
media and they also exhibited no appreciable change in
their shapes. In Figure 3, the mass loss results calculated
according to Equation (3) by measuring the weight of the
dried hydrogels are given. As it can be seen from the graph,
the total mass loss of the FPEG20-2 hydrogel at the end of
the 52nd week was 73% while the other hydrogels
FPEG30-2 and FPEG40-2 were 54 and 42%, respectively.
The decrease in the degradation was probably because of
the existence of PEGDAunits.[32] In contrast to the constant
swelling ratio during degradation, after drying, the
hydrogels became very weak and crumbled upon hand-
ling, which is typical of degrading networks.
Solution Viscosity
The principle behind the design of an injectable biomater-
ial lies in the ability to syringe its uncured solution into a
damaged area in vivo easily and to fill the area completely.
Hence, the viscosity of the solution becomes important.
The viscosity of the uncured compositions was investi-
gated and the results are given in Table 2. The viscosities
were found to fall from 85 to 36 cP as the PEGDA content is
Figure 3. Degradation results of total mass loss of the hydrogels.
Macromol. Biosci. 2008, 8, 852–862
� 2008 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
increased from 20 to 40%. The viscosity results demon-
strate that all formulations are suitable to use as an
injectable biomaterial.
Compressive Mechanical Testing
Hydrogels that are used in biomedical applications should
necessarily meet strict performance requirements, such as
significant mechanical strength when in contact with
body fluid. The mechanical properties of the hydrogels
were evaluated by compressive mechanical testing.
Compressive testing is preferred to determine themaximal
compressive stress that a sample can withstand. It
measures the stiffness of a given material, which reflects
the resistance of an elastic body against the deflection of
an applied force.[28] Stress–strain plots are given in
Figure 4. In Table 2, the compressive modulus and the
fracture strengths of the samples are given in the wet
state. The elastic modulus varied between 0.74� 0.05 and
3.60� 0.23 N �mm�2, while the fracture strength varied
between 0.11� 0.02 and 1.09� 0.12 N �mm�2. It is clearly
seen that the values increase in order. As it is well known,
the crosslinking density and heterogeneities such as
cyclization, unreacted oligomers, and trapped radicals
significantly affect the mechanical properties of the
hydrogels.[8] The hydrogel with 40 wt.-% PEGDA
(FPEG40-2) has an elastic modulus almost five times
greater than that with 20 wt.-% PEGDA (FPEG20-2). It is
thought that the greater reactive acrylate group fraction of
the former hydrogel makes it more crosslinked. In
addition, the molecular weight of PEGDA is lower than
themolecular weight of fumarated PEGDGE. Therefore, the
molecular weight between two crosslink points decreases
as the PEGDA content of the network increases. The tensile
strength of sample FPEG40-2 is ten times higher than that
of FPEG20-2. These results indicate that the mechanical
properties of the hydrogels depend on the crosslink density
of the network and the molecular weight between
crosslink points.
Figure 4. Stress–strain curves of cylindrical specimens loaded incompression test.
DOI: 10.1002/mabi.200700319
Photopolymerized Injectable RGD-Modified Fumarated Poly(ethylene glycol) . . .
Figure 5. a) Conversion of double bonds and b) rate of polymeri-zation.
Differential Photocalorimetry
The rate of polymerization of hydrogel formulations was
studied with photo-DSC. The raw data obtained from
photo-DSC were the heat flow difference between a
reference cell and the cell that contained the hydrogel
formulation. A baseline correction for the heat flow was
performed in order to eliminate heat effects caused by
irradiation.[29] Figure 5a,b show the rate of polymerization
and double bond conversion versus time, respectively. As
seen in Figure 5a, FPEG20-2 showed a slightly lower rate of
polymerization compared to FPEG40-2. All formulations
display three distinct rate of polymerization stages that
are initially fast, then level off for a prolonged duration,
and then finally decrease due to the controlled propagation
and termination reactions. It has previously been reported
that the multifunctional monomers exhibit auto-
acceleration-induced behavior that leads to the very rapid
crosslinking process.[33] As seen in Figure 4b the double
bond conversion was obtained on the order of 0.7–0.9. At a
Macromol. Biosci. 2008, 8, 852–862
� 2008 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
higher PEGDA content, the conversion reached 0.92. This
result demonstrates the lower reactivity and mobility of
the fumarated PEGDGE as a result of its higher molecular
weight and viscosity. Also the steric hinderance slows
down the addition of fumaric acid double bonds of the
fumarated PEGDGE resin to the polymer chain. Table 2 also
shows the reaction heat liberated during polymerization
and it varied between 20.74 and 25.93 J � g�1 with the
greatest value obtained for FPEG40-2. It can be seen in
Figure 5a that the crosslinking of the hydrogel formulation
is a very rapid process, in which gelation often occurs in a
short time. The maximum heat release occurs between 2.5
and 15.5 s after UV radiation has commenced. The short
times at which the maximum heat release and the low
heat release values obtained are encouraging for in-situ
curing applications to minimize adverse bone tissue
responses.[24] The heat of polymerization for poly(methyl
methacrylate) was reported as 54.75 kJ �mol�1 (547.5 J �g�1) and the curing time was given as 5–10 min.[34,35] The
intensity of the UV-light also had an effect on the in-situ
polymerization.[22,25] Amsden et al.[22] fabricated their
elastomer device by using 100mW � cm�2 long-wave
ultraviolet light (320–480 nm) at room temperature for
5min and reported that after photopolymerization more
than 80% of the bioactivity of the therapeutic proteins was
retained. A photo-DSC device that had filtered light
(250–450 nm) with an intensity of 20mW � cm�2 was
used for photopolymerization. It is clearly seen that the
intensity of the UV light is applicable for clinical use and
not harmful for cells or tissues.
In vitro Studies of the Cell Seeded Hydrogels
The main objective of this study was to design a new
injectable polymer that could be used as a scaffold for cell
growth. For this reason, first the interaction between the
hydrogels and cells was investigated by using invert
microscopy. Images of the 3T3 mouse fibroblasts, which
were taken after 48 h on the Petri dishes where they
remained during culture, can be seen in Figure 6.
The growth of 3T3 mouse fibroblasts on the hydrogel
surface was monitored by environmental scanning
electron microscopy (ESEM). The ESEM technique makes
it possible to examine materials in their natural, uncoated
state under low vacuum. During in-situ testing of
uncoated samples, the absence of charge formation in
this system provides an obvious advantage. The sample
morphologies were investigated at room temperature to
reveal their natural surface characteristics by using a
special technique (gaseous low vacuummode) that allows
charge-free, gaseous secondary electrons.[36] Attachment
of fibroblasts on the hydrogels having no RGD peptide unit
was very poor; however, cell adhesion was significantly
www.mbs-journal.de 859
Z. S. Akdemir, H. Akcakaya, M. V. Kahraman, T. Ceyhan, N. Kayaman-Apohan, A. Gungor
Figure 6. Light microscope images of the fibroblasts after 48 hinteraction with hydrogel sample (FPEG20) on the Petri disheswhere they remained during culture.
Figure 8. SEM micrographs of 3T3 fibroblasts cultured on thesurface of sample FPEG20-2, 24 h following seeding a) �500and b) �9 000 magnification.
860
enhanced for the hydrogel that had RGD peptide units
(FPEG20-2) (Figure 7). It was observed that the cells did not
vanish or lose their original structural shapes, and they
also adhered to the surface of the hydrogels. This is strong
proof that the hydrogels that have RGD units are
biocompatible materials and do not exhibit a toxic
character. Also, in Figure 7 it can clearly be seen that
some of the cells have started to divide.
The interaction of FPEG20-6 with 3T3 cells was also
investigated by SEM to improve resolution. SEM images
show that the surface of the hydrogel with RGD peptide
was cell adhesive and a large number of fibroblasts on its
surface are observed (Figure 8a,b). As seen in Figure 8b, a
spheroid cell with one to two filapodial extensions at high
magnification demonstrate cell spreading. It is known that
cell adhesion involves a sequence of four steps: cell
Figure 7. ESEM images taken 24 h after cell seeding and in-vitrogrowth of 3T3 mouse fibroblasts. Hydrogel with RGD peptideunits (FPEG20-2)
Macromol. Biosci. 2008, 8, 852–862
� 2008 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
attachment, cell spreading, organization of an actin
cytoskeleton, and formation of focal adhesions.[37]
To further establish the effect of hydrogel RGD peptide
content on the cell adhesion, the hydrogels with 0–6 wt.-%
RGD-PEGMAwere prepared. The compositions are given in
Table 1. Osteoblasts were seeded onto the sterilized
hydrogel surface. As shown in Figure 9a, after 24 h only
rounded cells were observed on the hydrogel having no
RGD. However, some cell spreading is seen on the hydrogel
with 2 wt.-% RGD. In the case of the 6 wt.-% RGD-
PEGMA-containing hydrogel, the surface image has
changed significantly and a lace-like cell layer is observed
throughout the surface. A similar observation was
previously reported by Burdick and Anseth.[38] They
observed a significant increase in cell number and cell
spreading upon increase in the RGD concentration. It is
also observed that, while the hydrogel with the highest
RGD content (FPEG20-6) exhibits a very porous structure
(not shown here), all the pores are closed after the cell
DOI: 10.1002/mabi.200700319
Photopolymerized Injectable RGD-Modified Fumarated Poly(ethylene glycol) . . .
Figure 9. SEM micrographs of osteoblasts cultured on the surfaceof a) FPEG20, b) FPEG20-2, and c) FPEG20-6 samples, 24 hfollowing seeding.
Table 3. SEM-EDS analysis results of the FPEG20-6 hydrogelsurface before cell seeding and after cell seeding.
Surface Spectrum Total
C N O Na Cl Ca
Empty
surface
55.45 – 39.18 0.57 4.80 – 100.00
Cell-seeded
surface
58.32 10.12 27.78 0.56 2.94 0.29 100.00
seeding experiment. This is attributed to the good
adhesion and spreading of cells inside the pores. Pre-
viously, He et al. reported that the collagen-coated electro-
spun polylactide showed enhanced endotheliazation and
Macromol. Biosci. 2008, 8, 852–862
� 2008 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
increased cell viability and attachment because of its
fibrillar morphology.[39] Moreover, Woo et al. reported that
cell adhesion to fibrous scaffolds was different from that to
solid-walled scaffolds. They showed that abundant long
slender shaped osteoblasts were formed and they were
very difficult to distinguish from the polymeric scaffold.[40]
Scanning electron microscopy and energy dispersive
spectrometry (SEM-EDS) was used to identify the chemical
composition or the distribution of elements on the hydro-
gel surface before and after cell seeding for sample
FPEG20-6. As shown in Table 3, it was determined that
the RGD-modified hydrogel surface includes quite high
amounts of nitrogen and calcium atoms. This result
reveals that nitrogen and calcium are produced on the
osteoblast-seeded surface of the scaffoldwithin the culture
time period. However, nitrogen and calcium deposition
was not detected on the RGD-containing hydrogel scaffold
without cells. It is well known that Type I collagen is the
predominant component of a complex secreted extra-
cellular matrix that supports the process of tissue
mineralization to form calcified bone.[41] Osteoblasts can
expand on the hydrogel surface and, due to the osteoid
activity, collagen secretion takes place which increases the
nitrogen percentage on the hydrogel surface and miner-
alization, which can be determined by SEM-EDS studies.
Although this paper presents in-vitro studies, future
research will focus on the in-vivo study of the hydrogels,
which will be placed into the tibea of rats.
Conclusion
New injectable fumarated PEGDA-based polymer net-
works are prepared by a photopolymerization technique.
The swelling ratio of the hydrogels is decreased with the
increase in the PEGDA content, which, on the other hand,
enhances the crosslinking degree. The viscosities of the
formulations were dependent on the PEGDA content,
which reduces the viscosity significantly because of its low
molecular weight. The fracture strength and compressive
www.mbs-journal.de 861
Z. S. Akdemir, H. Akcakaya, M. V. Kahraman, T. Ceyhan, N. Kayaman-Apohan, A. Gungor
862
modulus of the hydrogels tested in this study are also
affected by the PEGDA content. Cell growth experiments
showed that the RGD peptide unit facilitated the adhesion
of the cells to the hydrogel surface.
Acknowledgements: This work was supported by TUBITAK TBAGProject no: 105T254. The authors thank Assoc. Prof. Dr. YusufMenceloglu for 1H NMR measurements.
Received: December 5, 2007; Revised: March 19, 2008; Accepted:March 25, 2008; DOI: 10.1002/mabi.200700319
Keywords: cell growth; hydrogels; photopolymerization; RGD
[1] B. D. Ratner, A. S. Hoffman, F. J. Schoen, J. E. Lemons, ‘‘Bio-materials Science, An Introduction to Materials in Medicine’’,2nd Edition, Elsevier, Academic Press, USA 2004.
[2] H.-Y. Cheung, K.-T. Lau, T.-P. Lu, D. Hui, Compos. B 2007, 38,291.
[3] J. E. Babensee, J. M. Anderson, L. V. McIntire, A. G. Mikos, Adv.Drug Delivery Rev. 1998, 33, 111.
[4] A. S. Hoffman, Adv. Drug Delivery Rev. 2002, 43, 3.[5] H. Shin, P. Q. Ruhe, A. G.Mikos, J. A. Jansen, Biomaterials 2003,
24, 3201.[6] C. R. Nuttelman, K. S. Anseth, Polym. Prepr. (Am. Chem. Soc.,
Div. Polym. Chem.) 2000, 41, 1685.[7] C. R. Nuttelman, S. M. Henry, K. S. Anseth, Biomaterials 2002,
23, 3617.[8] J. A. Burdick, L. M. Philpott, K. S. Anseth, J. Polym. Sci., Part A:
Polym Chem. 2001, 39, 683.[9] A. Porjazoska, O. Karal Yılmaz, K. Baysal, M. Cvetkovska, S.
Sırvancı, F. Ercan, B. Baysal, J. Biomater. Sci., Polym. Ed. 2006,17, 323.
[10] Y. Mc Lee, S. S. Kim, Polymer 1997, 38, 2415.[11] H. J. Lee, J.-S. Lee, T. Chansakul, C. Yu, J. H. Elisseeff, S. M. Yu,
Biomaterials 2006, 27, 5268.[12] S. R. Peyton, C. B. Raub, V. P. Keschrumrus, A. J. Putnam,
Biomaterials 2006, 27, 4881.[13] T. Taguchi, L. Xu, H. Kobayashi, A. Taniguchi, K. Kataoka,
J. Tanaka, Biomaterials 2005, 26, 1247.[14] J. A. Burdick, M. N. Mason, A. D. Hinman, K. Thorne, K. S.
Anseth, J. Controlled Release 2002, 83, 53.[15] S. Jo, P. S. Engel, A. G. Mikos, Polymer 2000, 41, 7595.
Macromol. Biosci. 2008, 8, 852–862
� 2008 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
[16] D. L. Hern, J. A. Hubbell, J. Biomed. Mater. Res. 1998, 39,266.
[17] F. M. Veronese, G. Pasut, Drug Discovery Today 2005, Vol. 10, ,Number . 21.
[18] P. B. Malafaya, G. A. Silva, E. T. Baran, R. L. Reis, Curr. Opin.Solid State Mater. Sci 2002, 6, 297.
[19] D. Kretlow, L. Klouda, A. G. Mikos, Adv. Drug Delivery Rev.2007, 59, 263.
[20] H. J. Chung, T. G. Park, Adv. Drug Delivery Rev. 2007, 59, 249.[21] C. G. Williams, A. N. Malik, T. K. Kim, P. N. Manson, J. H.
Elisseeff, Biomaterials 2005, 26, 1211.[22] Q. Li, J.Wang, S. Shahani, D. D. N. Sun, B. Sharma, J. H. Elisseeff,
K. W. Leong, Biomaterials 2006, 27, 1027.[23] K. T. Nguyen, J. L. West, Biomaterials 2002, 23, 4307.[24] J. P. Fisher, D. Dean, A. G. Mikos, Biomaterials 2002, 23, 4333.[25] K. S. Anseth, A. T. Metters, S. J. Bryant, P. J. Martens, J. H.
Elisseef, C. N. Bowman, J. Controlled Release 2002, 78, 199.[26] F. Yang, C. G. Williams, D.-A. Wang, H. Lee, P. N. Manson,
J. Elisseeff, Biomaterials 2005, 26, 5991.[27] B. H. Zhao, W. M. Tian, H. L. Feng, I.-S. Lee, F. Z. Cui, Curr. Appl.
Phys. 2005, 5, 407.[28] E. Oral, N. A. Peppas, Polymer 2004, 45, 6163.[29] F. Brandl, F. Sommer, A. Goepferich, Biomaterials 2007, 28,
134.[30] E. Andrzejewska, M. Andrzejewski, J. Polym. Sci., Part A:
Polym. Chem. 1998, 36, 665.[31] E. Kılıc T. Ceyhan, D. Uckan Temizkan, Acta Orth. et Traum.
Turcica 2007, 41, 295.[32] S. Varghese, N. S. Hwang, A. C. Canver, P. Theprungsirikul,
D. W. Lin, J. Elisseeff, J. Matrix Biol. 2008, 27, 12.[33] H. Wang, J. Wei, X. Jiang, J. Yin, Polymer 2006, 47, 4967.[34] T. F. Scott, W. D. Cook, J. S. Forsythe, Polymer 2002, 43, 5839.[35] K. D. Kuhn, ‘‘Bone Cements’’, Springer. Berlin, Germany: 2000,
pp. 21–26.[36] O. Karal-Yilmaz, N. Kayaman-Apohan, Z. Mısırlı, K. Baysal,
B. M. Baysal, J. Mater. Sci: Mater. Med. 2006, 17, 213.[37] S. Drotleff, U. Lungwitz, M. Breunig, A. Dennis, T. Blunk,
J. Tessmar, A. Gopferich, Eur. J. Pharm. Biopharm. 2004, 58,385.
[38] J. A. Burdick, K. S. Anseth, Biomaterials 2002, 23, 4315.[39] W. He, Z. Ma, T. Yong, W. E. Teo, S. Ramakrishna, Biomaterials
2005, 26, 7606.[40] K. M. Woo, J.-H. Jun, V. J. Chen, J. Seo, J.-H. Baek, H.-M. Ryoo,
G.-S. Kim, M. J. Somerman, P. X. Ma, Biomaterials 2007, 28,335.
[41] S. M. Morgan, S. Tilley, S. Perera, M. J. Ellis, J. Kanczler, J. B.Chaudhuri, R. O. C. Oreffo, Biomaterials 2007, 28, 5332.
DOI: 10.1002/mabi.200700319